Pôle Cardiovasculaire et Métabolique, CHU Rangueil, Toulouse, France.
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):E124-7. doi: 10.1002/ccd.24541. Epub 2012 Nov 14.
Transcatheter aortic valve implantation is a possible, although off-label, alternative to conventional aortic valve replacement for high-surgical-risk patients with severe, non-calcified aortic regurgitation (AR). To date, feasibility has only been demonstrated with the Medtronic CoreValve prosthesis (MCV). This prosthesis needs the aortic sinuses to have enough width to avoid coronary obstruction. We report a case of MCV implantation for severe AR where the narrow aortic root theoretically precluded the technique. Good procedural outcome was achieved thanks to a strategy of implantation with planned positioning of the prosthesis leaflets away from the coronary arteries.
经导管主动脉瓣植入术是一种可能的替代方法,尽管是非适应证的,用于治疗高危外科手术风险的严重非钙化性主动脉瓣反流(AR)患者。到目前为止,只有美敦力 CoreValve 假体(MCV)证明了该方法的可行性。该假体需要主动脉窦有足够的宽度以避免冠状动脉阻塞。我们报告了一例因严重 AR 而植入 MCV 的病例,理论上狭窄的主动脉根部排除了该技术的应用。由于采用了将假体瓣叶远离冠状动脉的计划定位策略,因此手术过程取得了良好的效果。